4-1BB抗体在瘤学临床试验中的研究:一篇综述
Robin Schwartz1, Keerti Vajrala2, Gerald S Falchook1
1Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.
Journal of immunotherapy and precision oncology
|March 28, 2025
概括
4-1BB激动剂是激活T细胞的有希望的癌症免疫疗法. 本综述涵盖了临床试验中的4-1BB抗体,并指出它们的抗瘤作用和常见副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 4-1BB (CD137) 是T淋巴细胞上的一种跨膜糖蛋白.
- 4-1BB信号促进T细胞的激活和分化,特别是CD8+细胞毒性T细胞.
- 它在增强抗瘤免疫力的作用使其成为癌症免疫治疗的关键目标.
研究的目的:
- 审查4-1BB抗体在癌症治疗中的开发和临床应用.
- 总结正在进行的临床试验中的4-1BB向剂的疗效和安全性概况.
主要方法:
- 对涉及4-1BB抗体的临床前研究和临床试验的文献综述.
- 对治疗疗效和观察到的不良事件数据的分析.
主要成果:
- 4-1BB抗体在各种临床前模型和人体试验中显示出显著的抗瘤活性.
- 观察到的关键副作用包括转氨酶升高,细胞衰竭,疲劳和恶心.
- 几种4-1BB抗体正在经历临床瘤学试验的不同阶段.
结论:
- 4-1BB抗体代表了癌症治疗的有前途的免疫治疗药物类别.
- 持续的临床研究对于优化它们的使用和管理副作用至关重要.
- 在瘤学中,4-1BB激素的治疗潜力是相当大的.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


